These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2297705)

  • 1. A Mr 43,000 epidermal growth factor-related protein purified from the urine of breast cancer patients.
    Eckert K; Granetzny A; Fischer J; Nexø E; Grosse R
    Cancer Res; 1990 Feb; 50(3):642-7. PubMed ID: 2297705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of a high molecular weight form of epidermal growth factor from urine of breast cancer patients.
    Eckert K; Granetzny A; Fischer J; Grosse R
    Biomed Biochim Acta; 1989; 48(1):111-20. PubMed ID: 2789043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human A673 cells secrete high molecular weight EGF-receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF-alpha.
    Stromberg K; Hudgins WR; Fryling CM; Hazarika P; Dedman JR; Pardue RL; Hargreaves WR; Orth DN
    J Cell Biochem; 1986; 32(4):247-59. PubMed ID: 3492500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.
    Zarnegar R; Michalopoulos G
    Cancer Res; 1989 Jun; 49(12):3314-20. PubMed ID: 2524251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant forms of rat epidermal growth factor present in the urine of nude rats bearing human tumors.
    Hudgins WR; Orth DN; Stromberg K
    Cancer Res; 1988 Mar; 48(6):1428-34. PubMed ID: 3257897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
    Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
    Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
    Stromberg K; Hudgins WR
    Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human brain tumor-associated urinary high molecular weight transforming growth factor: a high molecular weight form of epidermal growth factor.
    Stromberg K; Hudgins WR; Dorman LS; Henderson LE; Sowder RC; Sherrell BJ; Mount CD; Orth DN
    Cancer Res; 1987 Feb; 47(4):1190-6. PubMed ID: 3026622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplicity of transforming growth factors in human malignant effusions.
    Seo MK; Lynch KE; Podolsky DK
    Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer.
    Sherwin SA; Twardzik DR; Bohn WH; Cockley KD; Todaro GJ
    Cancer Res; 1983 Jan; 43(1):403-7. PubMed ID: 6600160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial purification of transforming growth factors from human milk.
    Zwiebel JA; Bano M; Nexo E; Salomon DS; Kidwell WR
    Cancer Res; 1986 Feb; 46(2):933-9. PubMed ID: 3000589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between 43 kDa epidermal growth factor-related clonogenic activity and clinical parameters for breast cancer.
    Eckert K; Granetzny A; Fischer J; Grosse R
    Anticancer Res; 1991; 11(6):2125-30. PubMed ID: 1776851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of a novel transforming growth factor.
    Halper J; Moses HL
    Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of epidermal growth factor as a component of the rat urinary bladder tumor-enhancing urinary fractions.
    Yura Y; Hayashi O; Kelly M; Oyasu R
    Cancer Res; 1989 Mar; 49(6):1548-53. PubMed ID: 2784351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoma growth factor (SGF): specific binding to epidermal growth factor (EGF) membrane receptors.
    De Larco JE; Todaro GJ
    J Cell Physiol; 1980 Feb; 102(2):267-77. PubMed ID: 6246130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of urinary transforming growth factor-alpha in women with disseminated breast cancer and healthy control women.
    Stromberg K; Duffy M; Fritsch C; Hudgins WR; Sharp ES; Murphy LD; Lippman ME; Bates SE
    Cancer Detect Prev; 1991; 15(4):277-83. PubMed ID: 1794134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factors in the urine of normal, pregnant, and tumor-bearing humans.
    Twardzik DR; Sherwin SA; Ranchalis J; Todaro GJ
    J Natl Cancer Inst; 1982 Oct; 69(4):793-8. PubMed ID: 6288992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of growth factors functionally related to epidermal growth factor in the urine of normal and human tumor-bearing athymic mice.
    Twardzik DR; Kimball ES; Sherwin SA; Ranchalis JE; Todaro GJ
    Cancer Res; 1985 May; 45(5):1934-9. PubMed ID: 3872712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
    Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
    Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.